Lovastatin Patent Expiration
Lovastatin is Used for decreasing A-beta production in patients at risk of or exhibiting symptoms of Alzheimer's disease. It was first introduced by Merck Research Laboratories Div Merck Co Inc
Lovastatin Patents
Given below is the list of patents protecting Lovastatin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Altoprev | US6080778 | Methods for decreasing beta amyloid protein |
Mar 23, 2018
(Expired) | Covis |
| Altoprev | US5916595 | HMG co-reductase inhibitor |
Dec 12, 2017
(Expired) | Covis |
| Altoprev | US6485748 | Once daily pharmaceutical tablet having a unitary core |
Dec 12, 2017
(Expired) | Covis |
Lovastatin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List